Logo.png
Ocean Biomedical (NASDAQ: OCEA) Announces New Patent for Anti-Fibrosis Discovery with Allowance in Alcoholic Liver Disease and Multiple Fibrotic Conditions, Leading Causes of Death in the U.S.
29 août 2023 08h01 HE | Ocean Biomedical, Inc.
Ocean’s small molecule candidate significantly controls fibrosis progression in idiopathic pulmonary fibrosis (IPF) and Hermansky-Pudlak Syndrome (HPS) in multiple testing models. Patent granted for...
biomerica.png
Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients
21 juin 2023 08h19 HE | Biomerica, Inc.
Patent Claims Describe a Novel System to Predict and Help Prevent Adverse Food Reactions Using Personal Medical DataThe Patent further describes Algorithms to help Determine Safety Levels of Food...
guident-logo-web.png
GUIDENT Secures New Patent with Advanced Methods for Remote Monitoring of Vehicles
14 juin 2023 13h15 HE | Guident Ltd.
BOCA RATON, FL , June 14, 2023 (GLOBE NEWSWIRE) -- Guident, a leading autonomous vehicle teleoperation company with HQ's in Boca Raton, Florida, is pleased to announce that it has received notice of...
Tricol Biomedical Ex
Tricol Biomedical Expands IP Protection with First New Patent for Gastrointestinal Hemostasis
21 févr. 2023 10h00 HE | Tricol Biomedical
Portland, OR, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The US Patent and Trademark Office has granted Tricol Biomedical, a global leader in innovating hemostasis and wound care solutions, a new patent...
LOGO.jpg
Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment
03 janv. 2023 09h30 HE | Vivos Inc.
Richland WA, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that they filed a provisional patent application on the system equipment to support precision...
DeCurtis Corporation
DeCurtis Corporation Receives Patent on a Method to Improve Fidelity and Reduce Traffic Incurred for Location Services
13 juil. 2021 08h30 HE | DeCurtis Corporation
Orlando, Florida, July 13, 2021 (GLOBE NEWSWIRE) -- DeCurtis Corporation has been awarded a new patent titled "Beacon Reader with Reduced Network Data Traffic," once again improving...
CBondlogo-Red.png
C-Bond Systems Receives Notice of Allowance from U.S. Patent and Trademark Office for Seminal Glass Strengthening Patent
11 mai 2021 08h30 HE | C-Bond Systems
HOUSTON, May 11, 2021 (GLOBE NEWSWIRE) -- C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has received a notice of allowance from...
biomerica.png
Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020
15 avr. 2021 10h31 HE | Biomerica, Inc.
Sales increase driven by first sales of COVID-19 Antigen Rapid Test in Europe after January 2021 CE Mark approval Awarded two new patents for InFoods® diagnostic guided therapy technology, including...
Screen Shot 2020-07-28 at 11.27.29 AM.png
American BriVision Announces New Patent Filed for Treatment of Major Depressive Disorder
24 août 2020 09h00 HE | American BriVision Holding Corporation
FREMONT, CA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ American BriVision (Holding) Corporation (OTCQB: ABVC) (the “Company”), a clinical-stage biopharmaceutical company developing...
biomerica.png
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)
08 avr. 2019 08h19 HE | Biomerica, Inc.
IRVINE, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for...